Calyxo
CA - PleasantonBiotechnology
Focus: Calyxo develops medical devices for kidney stone treatment, focusing on minimally invasive urological interventions in the nephrology space. The company operates as a device-focused biotechnology firm headquartered in Pleasanton, California.
Profile data last refreshed 2h ago · AI intelligence enriched 2w ago
Open Jobs
32+6 this month
Growing — net +6 jobs in 30d
23 jobs added vs 17 removed. Steady team buildout.
Should You Work at Calyxo?
AI assessmentCalyxo presents a device-stage growth opportunity in nephrology if capitalization and clinical progress are solid, but limited transparency warrants due diligence before committing.
Why Work Here
- Active hiring across 26 open roles with heavy investment in Clinical Excellence (8 roles) and Quality Assurance (5 roles), signaling commercialization momentum
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
5 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
SURE
Kidney StoneClinical Trials (1)
NCT04519294Comparison of Laser Lithotripsy With and Without Steerable Ureteroscopic Renal Evacuation (SURE)
N/AHelp build intelligence for Calyxo
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.